0001529224-21-000004.txt : 20211007 0001529224-21-000004.hdr.sgml : 20211007 20211007164040 ACCESSION NUMBER: 0001529224-21-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211007 DATE AS OF CHANGE: 20211007 EFFECTIVENESS DATE: 20211007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GeneCentric Therapeutics, Inc. CENTRAL INDEX KEY: 0001529224 IRS NUMBER: 452540158 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-416162 FILM NUMBER: 211312797 BUSINESS ADDRESS: STREET 1: 100 CAPITOLA DRIVE STREET 2: SUITE 275 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: (919) 973-6544 MAIL ADDRESS: STREET 1: 100 CAPITOLA DRIVE STREET 2: SUITE 275 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: GeneCentric Diagnostics, Inc. DATE OF NAME CHANGE: 20110902 D 1 primary_doc.xml X0708 D LIVE 0001529224 GeneCentric Therapeutics, Inc. 100 CAPITOLA DRIVE SUITE 275 DURHAM NC NORTH CAROLINA 27713 (919) 973-6544 DELAWARE GeneCentric Diagnostics, Inc. Corporation true Michael V. Milburn 100 Capitola Drive Suite 275 Durham NC NORTH CAROLINA 27713 Executive Officer Director Myla V. Lai-Goldman 100 Capitola Drive Suite 275 Durham NC NORTH CAROLINA 27713 Executive Officer Director Clay V. Thorp 100 Capitola Drive Suite 275 Durham NC NORTH CAROLINA 27713 Director Perou V. Charles 100 Capitola Drive Suite 275 Durham NC NORTH CAROLINA 27713 Executive Officer Director Arnold V. Levine 100 Capitola Drive Suite 275 Durham NC NORTH CAROLINA 27713 Director Ellen V. Lubman 100 Capitola Drive Suite 275 Durham NC NORTH CAROLINA 27713 Director Biotechnology Decline to Disclose 06b false 2021-09-22 false true false 0 7500000 4500000 3000000 false 1 0 0 0 false GeneCentric Therapeutics, Inc. /s/ Michael V. Milburn Michael V. Milburn President and CEO 2021-10-04